Special luncheon for Biology Graduate Students with Dr. Landel, Thursday May 9th at noon in THM 305/308.
Dr. Landel, currently with Transposagen Biopharmaceuticals, was part of our seminar series this past spring and has experience in both academic and industrial sectors. This will be an exceptional opportunity for the students to gather information about career opportunities. In addition, the founder of Transposagen will be developing a new company, which may align with the research interests of our graduate students.
Carlisle P. Landel Ph.D.
Director, Custom Animal Model Division
Transposagen Biopharmaceuticals
535 West Second St., Suite L102
Lexington, KY 40508
www.transposagenbio.com
clandel@transposagenbio.com
Transposagen Biopharmaceuticals, Inc., a Lexington, KY-based company, is a worldwide leader in technologies and services for genetic modification. Transposagen is dedicated to providing better disease models through genetic modification. Transposagen specializes in custom and off-the-shelf XTN™ site-specific nucleases, animal models, cell lines, stem cells and cutting-edge research tools and technologies to improve drug discovery and development research. These unique technologies and services for genetic modification give customers the ability to create nearly any genetic modification in any genome for both research and protein production purposes.